BioSpace News Archive

Medtronic plc (NYSE:MDT), the global leader in medical technology, today announced new clinical data from the NAVABLATE study, which highlights the much anticipated safety and performance results on microwave ablation used bronchoscopically with the Emprint™ Ablation Catheter Kit with Thermosphere™ Technology in conjunction with the Medtronic electromagnetic navigation bronchoscopy system.

Viracta Therapeutics, Inc. today announced that company management will present and be available for virtual one-on-one meetings at the H.C. Wainwright 23rd Annual Global Investment Conference, September 13 – 15, 2021

Syros Pharmaceuticals, a leader in the development of medicines that control the expression of genes, announced that its Chief Executive Officer, Nancy Simonian, M.D., will present a corporate overview at two upcoming investor conferences in September.

Flash Therapeutics, a CDMO with strong technological expertise, is accelerating the ramp-up of its biomanufacturing capabilities.

AFYX Therapeutics announced results from a preclinical study from the company’s collaboration with the University of Sheffield in the UK exploring the potential effects of delivering antibody fragments directly to inflamed tissue in mucosal diseases using Rivelin® technology.

MiMedx Group, Inc. today announced that Timothy R. Wright, Chief Executive Officer, Peter M. Carlson, Chief Financial Officer, and Robert B. Stein, M.D., Ph.D., Executive Vice President, Research and Development, will present at the H.C. Wainwright 23rd Annual Global Investment Conference held on September 13 - 15, 2021.

Ovid Therapeutics Inc. today announced that management will present in a virtual format at the H.C. Wainwright 23rd Annual Global Investment Conference.

Cidara Therapeutics, Inc. announced that Jeffrey Stein, Ph.D., president and chief executive officer, will participate in two upcoming investor conferences: the H.C. Wainwright 23rd Annual Global Investment Conference and Cantor Global Healthcare Conference.

BeyondSpring Inc. today announced that management will host a conference call to report its financial results for the second quarter ended June 30, 2021 and provide an update on recent corporate events on Friday, September 10, 2021 at 8:00 AM Eastern Time.

Motus GI Holdings, Inc. announced today that its management team is scheduled to participate at the two upcoming virtual investor conferences in September 2021.